C5AR1 and systemic lupus erythematosus: For example, in a model of lupus-like chronic graft-versus-host disease (GvHD), genetic or pharmacological ablation of C5aR1 in CD4+ T cells protected from the generation and expansion of TFH cells, GC B cells, and autoantibodies (74).